Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.16

€2.16

-
-
-
-
 
09.02.24 / Frankfurt WKN: A3EYCP / Name: Alzamend Neuro Inc. / Stock / ? / We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for Alzamend Neuro Inc.

sharewise wants to provide you with the best news and tools for Alzamend Neuro Inc., so we directly link to the best financial data sources.

News

Alzamend Neuro Announces Reverse Stock Split: https://mms.businesswire.com/media/20240712249038/en/835633/5/Alzamend_Neuro_-_Corporate_Logo_with_R_mark_10262020.jpg.jpg
Alzamend Neuro Announces Reverse Stock Split


Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheim